Sêmeia

Sêmeia is the French leader in remote patient monitoring. Its certified digital medical device platform automates the collection and analysis of health data to enable better monitoring of patients living with chronic conditions — for the benefit of patients, healthcare professionals and the healthcare system as a whole.

growth FUND

THE NEEDS THEY MEET

• Responding to the explosion of chronic diseases: up to 16 million patients and 75% of healthcare spending by 2035, in a context of growing medical workforce shortages and increasingly saturated healthcare facilities.
• Reducing inequalities in access to care: 27% of patients monitored by Sêmeia live in medical deserts.
• Relieving the burden on healthcare professionals and supporting medical decision-making, through the automated collection, structuring and restitution of patient data in the form of targeted alerts (thresholds set with physicians).
• Concretely improving the quality of life of patients with chronic conditions, through continuous monitoring, targeted alerts and treatments better tailored to their real-life situation.

WHAT CONVINCED US

• Proven and quantified organisational and clinical impact: 35,000 patients monitored across 500 healthcare facilities, −50% suicide attempts among monitored bipolar patients (2026 figures).
• A robust business model, underpinned by the reimbursement of the device by the French national health insurance, demonstrating Sêmeia’s ability to integrate durably into the French healthcare system.
• High-quality technology based on the automated collection of diverse data, generating reliable decision-support tools for practitioners.